DKSH launches Linco Care’s Re-Gen Oil in effort to expand in AP region

With a strong focus on Asia, the business healthcare unit of DKSH, well known for partnering with companies looking to grow their business in the region, has signed a three year agreement with Linco Care to provide marketing, sales and distribution as well as credit and collection services for its Re-Gen Oil in Malaysia.

According to DKSH representitives, the agreement highlights the company’s expertise to launch new products in competitive market environments and will further strengthen its' market position in the AP region.

“We are proud to support the launch of Re-Gen Oil in Malaysia and to provide our integrated Market Expansion Services to Linco Care to support their growth in Malaysia​,” says Irene Chan, general manager, Consumer Health and Specialty Group, DKSH Malaysia.

Most suitable partner for expansion​

On the partnership, managing director and co-founder of Linco Care, Farhad Seka says; "Our​ decision to outsource commercial and distribution services to DKSH is based on their capillary distribution network, expertise in marketing and selling skin care products as well as their dedication to quality and their ability to successfully launch new products​."

The Re-Gen Oil, according to the British manufacturer, is a skin treatment containing active ingredient PCL liquid specifically formulated for stretch marks, scars, blemished and wrinkled skin and helps to fight skin aging by reducing the oxidants and regenerating the skin.

"Alongside its natural ingredients such as lavender, calendula, chamomile and rosemary oils, it brings the beauty back with a special formulation by introducing a high level of moisture that improves wrinkled skin and skin with scar tissue."​

More and more companies breaking onto the AP region​

Munich-based Wacker also recently opted for DKSH to distribute its biotech products used for personal care applications in Asia taking advantage of the Zurich-headquartered firm’s presence in the region.

In that venture, the market expansion services provider was entrusted with the marketing and distribution of the distribution of cyclodextrins, cystine and cysteine in Southeast Asia, India and South Korea.